Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SPIRONOLACTONE Cause Atrioventricular block complete? 59 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Atrioventricular block complete have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.3% of all adverse event reports for SPIRONOLACTONE.

59
Reports of Atrioventricular block complete with SPIRONOLACTONE
0.3%
of all SPIRONOLACTONE reports
20
Deaths
53
Hospitalizations

How Dangerous Is Atrioventricular block complete From SPIRONOLACTONE?

Of the 59 reports, 20 (33.9%) resulted in death, 53 (89.8%) required hospitalization, and 24 (40.7%) were considered life-threatening.

Is Atrioventricular block complete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 59 reports have been filed with the FAERS database.

What Other Side Effects Does SPIRONOLACTONE Cause?

Acute kidney injury (3,273) Hyperkalaemia (2,518) Hypotension (1,583) Dyspnoea (1,468) Drug ineffective (1,379) Hyponatraemia (1,166) Dizziness (991) Fatigue (990) Fall (947) Off label use (899)

What Other Drugs Cause Atrioventricular block complete?

BISOPROLOL (261) VERAPAMIL (210) METOPROLOL (209) AMLODIPINE (149) DILTIAZEM (141) RITUXIMAB (139) AMIODARONE (138) LACOSAMIDE (130) ATORVASTATIN (127) PEMBROLIZUMAB (122)

Which SPIRONOLACTONE Alternatives Have Lower Atrioventricular block complete Risk?

SPIRONOLACTONE vs SPRYCEL SPIRONOLACTONE vs STALEVO SPIRONOLACTONE vs STANNOUS FLUORIDE SPIRONOLACTONE vs STANOZOLOL SPIRONOLACTONE vs STAVUDINE

Related Pages

SPIRONOLACTONE Full Profile All Atrioventricular block complete Reports All Drugs Causing Atrioventricular block complete SPIRONOLACTONE Demographics